Sunday, February 17, 2013
Room 207 (Hynes Convention Center)
This speaker is a leader in the field of cancer biology and innovative efforts to make large scale datasets broadly available to the research community for the purpose of identifying new drug leads. Open access to the experimental data underlying disease biology should increase understanding of disease and help to generate new drug targets and drug candidates.